The former pharmacy director at Children’s Hospital & Medical Center is accused of funneling more than $4.4 million from the organization into her personal account, state officials say.
According to a petition for disciplinary action filed by the Nebraska Attorney General’s Office, Lisa Kwapniowski created a company called RxSYnergy and submitted false invoices for a fictitious drug, “Broxcilam,” as well as others for legitimate medications, to the Omaha hospital. The petition presents a case for discipline against Kwapniowski's license to practice pharmacy.
Documents of incorporation for RxSYnergy filed with the state in March 2012 identify Kwapniowski as the president and sole member of the limited liability company, the petition indicates.
Kwapniowski told an investigator that the funds were deposited into a bank account created for RxSYnergy and eventually transferred to her personal account, according to the petition.
In June, according to the filing, she was terminated from the hospital after she was accused of embezzling money.
Kwapniowski could not immediately be reached for comment Monday.
Children’s officials said in a statement Monday that they learned of an “unfortunate situation” regarding an employee in June. The employee was terminated and the matter turned over to authorities for investigation, they said.
According to the petition, Kwapniowski submitted a total of 231 invoices from RxSYnergy to the hospital between April 2012 and June 2018 for payment, totaling more than $4.4 million.
The year-by-year breakdown:
» 2012: 6 invoices submitted for more than $76,000
» 2013: 17 invoices submitted for more than $216,000
» 2014: 28 invoices submitted for nearly $379,000
» 2015: 41 invoices submitted for nearly $726,000
» 2016: 52 invoices submitted for nearly $1.07 million
» 2017: 50 invoices submitted for more than $1.1 million
» 2018: 37 invoices submitted for more than $849,000
Kwapniowski has held a pharmacy license in Nebraska since 1994. A hearing is scheduled for Jan. 22.